A team of researchers recently reported that human genes may partially influence intestinal bacteria spurring inflammatory bowel disease (IBD) conditions like Crohn’s disease (CD) and ulcerative colitis (UC).
Modifying diet is one way to try to help patients with Irritable Bowel Syndrome (IBS). In a study reported in Gastroenterology, an Australian research team looked at the effects of lowering fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) vs. consuming a typical Australian diet.
Patients with irritable bowel syndrome with diarrhea (IBS-D) suffer not only the pain and discomfort of frequent loose stools, but fear of incontinence. For many patients, that results in panic and anxiety.
Study results published in the European Respiratory Journal show that rates of inflammatory bowel disease (IBD) incidence have significantly increased in individuals with asthma or chronic obstructive pulmonary disease (COPD).
Serum-derived bovine immunoglobulin/protein isolate appears to be a safe and effective nutritional moiety in patients with refractory IBS-D or IBS-M.
Not getting the right amount of sleep might raise the risk of ulcerative colitis, according to a study published in the November issue of Clinical Gastroenterology and Hepatology. Those who sleep less or more than the recommended seven to eight hours per night may be more prone to developing the chronic condition.